HPV−OPSCC of patients without LDR had altogether 64 TP53 mutations compared to 31 variants in HPV−OPSCC in patients with LDR; however, the median number of TP53 mutations per tumor is similar and the comparison did not reach significance (p = 0.540; Figure 2D). The gene discussed is TP53; the disease is neoplasm.